作者报告一组重症慢性活动性肝病以皮质激素治疗达到预定缓解标准,中止治疗后的临床特点和预后。预定的缓解标准为症状消失、GOT降至正常二倍以下、γ球蛋白和胆红质正常、肝活检无活动性肝病特点、组织学正常或有非特异性肝炎改变、无碎屑样坏死、无或有轻度炎性变化的肝硬化。 The authors report that a group of severe chronic active liver disease with corticosteroid treatment to achieve the desired standard of mitigation, termination of treatment after the clinical features and prognosis. Predetermined mitigation criteria for the symptoms disappear, GOT dropped to twice the normal, gamma globulin and bilirubin normal liver biopsy with no active liver disease, histological changes or non-specific hepatitis, non-debris-like necrosis, no Or cirrhosis with mild inflammatory changes.